$ALXA News
Last published 10y ago
- 10y agoHTGCWFCTPICJAZZ+12Hercules Announces Strong Second Quarter Financial Results with $0.32 NII per Share and a $0.31 Quarterly DividendBusiness WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the second quarter ended June 30, 2016.
- 10y agoHTGCJAZZCPXXPFE+5Hercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth StrategyBusiness WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today provided its portfolio update for Q2 2016.
- 10y agoALXAAlexza Pharmaceuticals' (ALXA) CEO Thomas King on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 12y agoALXAMedivir: Adasuve will now be launched in Sweden, Norway, Finland and DenmarkBusiness WireSTOCKHOLM--(BUSINESS WIRE)--Regulatory News:
- 13y agoTEVAALXATeva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.Business WireNORTH WALES, Pa. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) announced today that the companies have entered into an exclusive U.S. license and supply agreement for ADASUVE (loxapine) inhalation powder 10 mg for the acute treatment of agitation associated w ...
- 14y agoMCOHOKUQCONNPRU+2Alexza, AmBev, Coinstar, Conn, Sturm Ruger: U.S. Equity PreviewBloombergShares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses.